Cargando…
Left ventricular hypertrophy, dilatation and ejection fractions predict ventricular tachycardia in amyloid transthyretin cardiomyopathy
FUNDING ACKNOWLEDGEMENTS: Type of funding sources: Private company. Main funding source(s): Pfizer Global Medical Grant BACKGROUND: Amyloid transthyretin cardiomyopathy (ATTR-CM) is a progressive infiltrative cardiomyopathy caused by extracellular deposition of amyloid fibrils. The disease is charac...
Autores principales: | Knoll, K, Fuchs, P, Weidmann, I, Gross, S, Altunkas, F, Lennerz, C, Kolb, C, Kessler, T, Schunkert, H, Hengstenberg, W, Trenkwalder, T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207568/ http://dx.doi.org/10.1093/europace/euad122.274 |
Ejemplares similares
-
Ventricular tachycardia substrate ablation in patients with slightly depressed left ventricular ejection fraction. Predictors of VT-free survival in a prospective multicentre registry
por: Falasconi, G, et al.
Publicado: (2023) -
Age and genetics are associated with ventricular fibrillation but not with monomorphic ventricular tachycardia in Brugada syndrome
por: Pannone, L, et al.
Publicado: (2023) -
The long-term outcome of malignant outflow tract ventricular tachycardia in patients without structural heart disease
por: Kim, Y R, et al.
Publicado: (2023) -
Ventricular tachycardia predicts all-cause mortality and non-sudden cardiac death in non-ischaemic cardiomyopathy
por: Omara, S, et al.
Publicado: (2023) -
Incidence and predictors of new-onset sustained ventricular tachycardia in patients with cardiac sarcoidosis and high-grade AV block as first cardiac symptom
por: Dinov, B, et al.
Publicado: (2023)